SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-011902
Filing Date
2016-01-20
Accepted
2016-01-20 08:00:13
Documents
3
Period of Report
2016-01-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctmx-8k_20160120.htm 8-K 37626
2 EX-99.1 ctmx-ex991_6.htm EX-99.1 11752
3 GRAPHIC g201601200420363032724.jpg GRAPHIC 4559
  Complete submission text file 0001564590-16-011902.txt   56956
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 161349698
SIC: 2834 Pharmaceutical Preparations